[HTML][HTML] Cisplatin-induced ototoxicity: From signaling network to therapeutic targets

X Wang, Y Zhou, D Wang, Y Wang, Z Zhou… - Biomedicine & …, 2023 - Elsevier
Administration of cisplatin, a common chemotherapeutic drug, has an inevitable side effect
of sensorineural hearing loss. The main etiologies are stria vascularis injury, spiral ganglion …

[HTML][HTML] Cisplatin ototoxicity mechanism and antagonistic intervention strategy: a scope review

Y Li, T Zhang, Q Song, D Gao, Y Li, H Jie… - Frontiers in Cellular …, 2023 - frontiersin.org
Cisplatin is a first-line chemotherapeutic agent in the treatment of malignant tumors with
remarkable clinical effects and low cost. However, the ototoxicity and neurotoxicity of …

[HTML][HTML] Literature-based discovery predicts antihistamines are a promising repurposed adjuvant therapy for Parkinson's disease

G Tandra, A Yoone, R Mathew, M Wang… - International Journal of …, 2023 - mdpi.com
Parkinson's disease (PD) is a movement disorder caused by a dopamine deficit in the brain.
Current therapies primarily focus on dopamine modulators or replacements, such as …

Protective effects of esomeprazole against cisplatin-induced ototoxicity: an in vitro and in vivo study

H Jeon, IS Song, JG Park, H Lee, E Han, S Park… - Aquatic Toxicology, 2023 - Elsevier
In this study, we aimed to identify novel compounds that could afford protection against
cisplatin-induced ototoxicity by employing both cell-and zebrafish (Danio rerio)-based …

データベースを利活用した医学研究の取り組み事例

西村有平 - 日本鼻科学会会誌, 2024 - jstage.jst.go.jp
データベースを利活用した医学研究の取り組み事例 Toggle navigation J-STAGE home 資料・記事を
探す 資料を探す:資料タイトルから 資料を探す:分野から 資料を探す:発行機関から 記事を探す データ …